In continuation of our studies on the oil of cloves - a common kitchen
spice and a drug for home medicine - we have isolated and identified
two antiplatelet components, eugenol and acetyl eugenol. They inhibite
d arachidonate-, adrenaline- and collagen-induced platelet aggregation
; they were more potent in inhibiting aggregation by the first two ago
nists. Their inhibitory effect was reversible. These components were a
ntiaggregatory by a combination of at least two effects: (i) inhibitio
n of platelet thromboxane formation, and (ii) increased formation of 1
2-lipoxygenase products (12-HPETE). Though the presence of plasma prot
eins would reduce the effective concentration of these substances due
to binding, the relatively lower amounts of these components which inh
ibited arachidonate-induced aggregation when compared to their effects
on thromboxane production was intriguing. The answer might partly lie
in an increased formation of 12-HPETE facilitated by albumin which ac
ts as a 'conduit' to divert free arachadonic acid (AA) from the platel
et cyclooxygenase (CO) to the lipoxygenase pathway (22). Based on thei
r IC50 values, it was found that both eugenol and acetyl eugenol were
more potent than aspirin in inhibiting platelet aggregation induced by
arachidonate, adrenaline and collagen. In arachidonate-induced aggreg
ation eugenol was on a par with indomethacin. It was found that eugeno
l and acetyl eugenol when used in-combination potentiated inhibition o
f platelet aggregation induced by arachidonate, adrenaline and collage
n. This effect was, however, not evident from the metabolism of AA in
platelets; when used in combination the two compounds produced an addi
tive effect.